A detailed history of Resolute Advisors LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Resolute Advisors LLC holds 14,670 shares of RXRX stock, worth $88,460. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,670
Previous 14,670 -0.0%
Holding current value
$88,460
Previous $110,000 12.73%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$6.59 - $15.86 $24,172 - $58,174
3,668 Added 33.34%
14,670 $112,000
Q3 2022

Nov 14, 2022

BUY
$7.83 - $13.6 $14,360 - $24,942
1,834 Added 20.0%
11,002 $117,000
Q4 2021

Feb 14, 2022

BUY
$16.14 - $21.86 $147,971 - $200,412
9,168 New
9,168 $157,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.09B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Resolute Advisors LLC Portfolio

Follow Resolute Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Advisors LLC with notifications on news.